Skip to content
Agentic OS
Menu

Intelligence / Services / Auditor Changes / Benitec Biopharma Inc.

Auditchanged auditor (SEC 8-K)24 Sept 2026

Benitec Biopharma Inc.

24 Sept 2026: Changed auditor (SEC 8-K) · Ernst & Young LLP. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
24 Sept 2026
Ticker
BNTC
Sector
Pharma and biotech
Sic
2834
Items
4.01, 9.01
Location
Hayward, CA
State
California
Country
United States
SEC CIK
1808898
Reference
0001193125-26-401110
Engaged
Ernst & Young LLP
Event
Auditor dismissed
Summary
Baker Tilly US, LLP ("Baker Tilly"), the Company's independent registered public accounting firm, has served as the Company's auditor since 2020.
What this signal means

A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.

  1. Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
  2. 22 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Benitec Biopharma Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.

Start free

Across AOS Research

Other records for Benitec Biopharma Inc. in our registers.

More in Auditor dismissed

Auditor Changes

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.